BASE life science
George Hunnewell serves as the Senior Vice President and General Manager for the US at BASE life science since July 2023, contributing to tailored solutions in the life sciences industry. Previous roles include Corporate Advisor and Chief Executive Officer at RxPx, where innovative risk management strategies were developed from May 2019 to August 2024, and serving in several executive positions at prominent firms like PAREXEL International and Cogstate. George Hunnewell has a strong foundation in life sciences investment and corporate development, having been a member of Mass Medical Angels and an Executive in Residence at SV Health Investors and Silversmith Capital Partners. Educational achievements include an MBA from MIT Sloan School of Management and a BA in Engineering Sciences from Harvard University.
This person is not in any offices